Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Jim Xiang

Showing results (111-120 of 169) with videos related to

Pageof 17
Sort By:
Plos One|October 17, 2012
CD154 and IL-2 signaling of CD4+ T cells play a critical role in multiple phases of CD8+ CTL responses following adenovirus vaccinationChannakeshava Sokke Umeshappa, Roopa Hebbandi Nanjundappa, Yufeng Xie, et al.
Cancer Biotherapy & Radiopharmaceuticals|September 6, 2008
Inhibition of pancreatic carcinoma growth by adenovirus-mediated human interleukin-24 expression in animal modelXinting Pan, Weihua Sheng, Qingyun Zhu, et al.
Cancer Gene Therapy|August 22, 2002
Enhanced HER-2/neu-specific antitumor immunity by cotransduction of mouse dendritic cells with two genes encoding HER-2/neu and alpha tumor necrosis factorZhuang Chen, Hui Huang, Tim Chang, et al.
Experimental Oncology|January 1, 2005
Enhanced antitumor immunity derived from a novel vaccine of fusion hybrid between dendritic and engineered myeloma cellsSiguo Hao, Xuguang Bi, Shuling Xu, et al.
Cancer Gene Therapy|February 22, 2002
Adenovirus-mediated CD40 ligand gene-engineered dendritic cells elicit enhanced CD8(+) cytotoxic T-cell activation and antitumor immunityYongqing Liu, Xuishu Zhang, Weidong Zhang, et al.
Journal of Immunology (Baltimore, Md. : 1950)|December 26, 2008
CD4+ Th-APC with acquired peptide/MHC class I and II complexes stimulate type 1 helper CD4+ and central memory CD8+ T cell responsesChannakeshava Sokke Umeshappa, Hui Huang, Yufeng Xie, et al.
The Journal of General Virology|December 20, 2005
Dendritic cells pulsed with hepatitis C virus NS3 protein induce immune responses and protection from infection with recombinant vaccinia virus expressing NS3Hong Yu, Hui Huang, Jim Xiang, et al.
Cancer Investigation|November 18, 2009
Recombinant human interleukin-24 suppresses gastric carcinoma cell growth in vitro and in vivoSu Yan, Haifeng Zhang, Yufeng Xie, et al.
Cellular & Molecular Immunology|September 4, 2007
Type 1 CD8+ T cells are superior to type 2 CD8+ T cells in tumor immunotherapy due to their efficient cytotoxicity, prolonged survival and type 1 immune modulationZhenmin Ye, Chaoke Tang, Shulin Xu, et al.
Digestion|July 25, 2013
On-demand proton pump inhibitory treatment in overweight/obese patients with gastroesophageal reflux disease: are there pharmacodynamic arguments for using higher doses?Stanislas Bruley des Varannes, Bogdana Coudsy, Sandra Waechter, et al.
Pageof 17

Showing results (111-120 of 169) with videos related to

Sort By:
Pageof 17
Plos One|October 17, 2012
CD154 and IL-2 signaling of CD4+ T cells play a critical role in multiple phases of CD8+ CTL responses following adenovirus vaccinationChannakeshava Sokke Umeshappa, Roopa Hebbandi Nanjundappa, Yufeng Xie, et al.
Cancer Biotherapy & Radiopharmaceuticals|September 6, 2008
Inhibition of pancreatic carcinoma growth by adenovirus-mediated human interleukin-24 expression in animal modelXinting Pan, Weihua Sheng, Qingyun Zhu, et al.
Cancer Gene Therapy|August 22, 2002
Enhanced HER-2/neu-specific antitumor immunity by cotransduction of mouse dendritic cells with two genes encoding HER-2/neu and alpha tumor necrosis factorZhuang Chen, Hui Huang, Tim Chang, et al.
Experimental Oncology|January 1, 2005
Enhanced antitumor immunity derived from a novel vaccine of fusion hybrid between dendritic and engineered myeloma cellsSiguo Hao, Xuguang Bi, Shuling Xu, et al.
Cancer Gene Therapy|February 22, 2002
Adenovirus-mediated CD40 ligand gene-engineered dendritic cells elicit enhanced CD8(+) cytotoxic T-cell activation and antitumor immunityYongqing Liu, Xuishu Zhang, Weidong Zhang, et al.
Journal of Immunology (Baltimore, Md. : 1950)|December 26, 2008
CD4+ Th-APC with acquired peptide/MHC class I and II complexes stimulate type 1 helper CD4+ and central memory CD8+ T cell responsesChannakeshava Sokke Umeshappa, Hui Huang, Yufeng Xie, et al.
The Journal of General Virology|December 20, 2005
Dendritic cells pulsed with hepatitis C virus NS3 protein induce immune responses and protection from infection with recombinant vaccinia virus expressing NS3Hong Yu, Hui Huang, Jim Xiang, et al.
Cancer Investigation|November 18, 2009
Recombinant human interleukin-24 suppresses gastric carcinoma cell growth in vitro and in vivoSu Yan, Haifeng Zhang, Yufeng Xie, et al.
Cellular & Molecular Immunology|September 4, 2007
Type 1 CD8+ T cells are superior to type 2 CD8+ T cells in tumor immunotherapy due to their efficient cytotoxicity, prolonged survival and type 1 immune modulationZhenmin Ye, Chaoke Tang, Shulin Xu, et al.
Digestion|July 25, 2013
On-demand proton pump inhibitory treatment in overweight/obese patients with gastroesophageal reflux disease: are there pharmacodynamic arguments for using higher doses?Stanislas Bruley des Varannes, Bogdana Coudsy, Sandra Waechter, et al.
Pageof 17